Pruritic intertriginous vesiculopustular eruption
Franziska Schauer(University of Freiburg), Johannes S. Kern(Monash Alfred Psychiatry Research centre), Kristin Technau‐Hafsi(University of Freiburg), David Rafei‐Shamsabadi(University Medical Center Freiburg), Melika Behzad(Philipps University of Marburg), Rüdiger Eming(Philipps University of Marburg), Andreas C. Renkl(University Hospital Ulm)
Cited by 0
Related Papers
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
|Science Translational Medicine|2013|246
Pemphigus: Current and Future Therapeutic Strategies
|Frontiers in Immunology|2019|245
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.
|Journal of Clinical Investigation|1998|235
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
|Arthritis Research & Therapy|2011|212